# US Foods Holding Corp.: financial statements, quarterly

USFD · NYSE · CIK 1665918 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jan 2

Pages: [Overview](/companies/usfd.md) · [Financials](/companies/usfd/financials.md) · [Filings](/companies/usfd/filings.md) · [Insiders](/companies/usfd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/usfd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [9.1](/filings/0001665918-24-000149.md) | [8.9 d](/filings/0001665918-26-000008.md) | [8.9](/filings/0001665918-25-000085.md) | [9.7](/filings/0001665918-25-000127.md) | [9.7](/filings/0001665918-25-000146.md) | [9.5 d](/filings/0001665918-26-000008.md) | [9.4](/filings/0001665918-26-000032.md) | [10.1](/filings/0001665918-26-000045.md) | [10.2](/filings/0001665918-25-000146.md) | [9.8 d](/filings/0001665918-26-000008.md) | [9.6](/filings/0001665918-26-000032.md) | [10.5](/filings/0001665918-26-000045.md) |
| Cost of revenue | $bn | [7.6](/filings/0001665918-24-000149.md) | [7.3 d](/filings/0001665918-26-000008.md) | [7.5](/filings/0001665918-25-000085.md) | [8.0](/filings/0001665918-25-000127.md) | [8.1](/filings/0001665918-25-000146.md) | [7.8 d](/filings/0001665918-26-000008.md) | [7.7](/filings/0001665918-26-000032.md) | [8.3](/filings/0001665918-26-000045.md) | [8.4](/filings/0001665918-25-000146.md) | [8.1 d](/filings/0001665918-26-000008.md) | [8.0](/filings/0001665918-26-000032.md) | [8.6](/filings/0001665918-26-000045.md) |
| Gross profit | $bn | [1.5](/filings/0001665918-24-000149.md) | [1.6 d](/filings/0001665918-26-000008.md) | [1.5](/filings/0001665918-25-000085.md) | [1.7](/filings/0001665918-25-000127.md) | [1.7](/filings/0001665918-25-000146.md) | [1.7 d](/filings/0001665918-26-000008.md) | [1.6](/filings/0001665918-26-000032.md) | [1.8](/filings/0001665918-26-000045.md) | [1.8](/filings/0001665918-25-000146.md) | [1.7 d](/filings/0001665918-26-000008.md) | [1.7](/filings/0001665918-26-000032.md) | [1.9](/filings/0001665918-26-000045.md) |
| Selling, general and administrative | $bn | [1.3](/filings/0001665918-24-000149.md) | [1.3 d](/filings/0001665918-26-000008.md) | [1.3](/filings/0001665918-25-000085.md) | [1.4](/filings/0001665918-25-000127.md) | [1.4](/filings/0001665918-25-000146.md) | [1.4 d](/filings/0001665918-26-000008.md) | [1.4](/filings/0001665918-26-000032.md) | [1.4](/filings/0001665918-26-000045.md) | [1.5](/filings/0001665918-25-000146.md) | [1.4 d](/filings/0001665918-26-000008.md) | [1.4](/filings/0001665918-26-000032.md) | [1.5](/filings/0001665918-26-000045.md) |
| Operating income | $bn | [0.2](/filings/0001665918-24-000149.md) | [0.3 d](/filings/0001665918-26-000008.md) | [0.2](/filings/0001665918-25-000085.md) | [0.4](/filings/0001665918-25-000127.md) | [0.3](/filings/0001665918-25-000146.md) | [0.3 d](/filings/0001665918-26-000008.md) | [0.2](/filings/0001665918-26-000032.md) | [0.4](/filings/0001665918-26-000045.md) | [0.3](/filings/0001665918-25-000146.md) | [0.3 d](/filings/0001665918-26-000008.md) | [0.2](/filings/0001665918-26-000032.md) | [0.4](/filings/0001665918-26-000045.md) |
| Interest expense | $bn | [0.1](/filings/0001665918-23-000144.md) | [0.1 d](/filings/0001665918-24-000014.md) | [0.1](/filings/0001665918-24-000101.md) | [0.1](/filings/0001665918-25-000127.md) | [0.1](/filings/0001665918-25-000146.md) | [0.1 d](/filings/0001665918-26-000008.md) | [0.1](/filings/0001665918-26-000032.md) | [0.1](/filings/0001665918-26-000045.md) | [0.1](/filings/0001665918-25-000146.md) | [0.1 d](/filings/0001665918-26-000008.md) | [0.1](/filings/0001665918-26-000032.md) | [0.1](/filings/0001665918-26-000045.md) |
| Income tax | $bn | [0.0](/filings/0001665918-24-000149.md) | [0.1 d](/filings/0001665918-26-000008.md) | [0.0](/filings/0001665918-25-000085.md) | [0.1](/filings/0001665918-25-000127.md) | [0.1](/filings/0001665918-25-000146.md) | [0.0 d](/filings/0001665918-26-000008.md) | [0.0](/filings/0001665918-26-000032.md) | [0.1](/filings/0001665918-26-000045.md) | [0.1](/filings/0001665918-25-000146.md) | [0.1 d](/filings/0001665918-26-000008.md) | [0.0](/filings/0001665918-26-000032.md) | [0.1](/filings/0001665918-26-000045.md) |
| Net income | $bn | [0.1](/filings/0001665918-24-000149.md) | [0.1 d](/filings/0001665918-26-000008.md) | [0.1](/filings/0001665918-25-000146.md) | [0.2](/filings/0001665918-25-000146.md) | [0.1](/filings/0001665918-25-000146.md) | [0.1 d](/filings/0001665918-26-000008.md) | [0.1](/filings/0001665918-26-000045.md) | [0.2](/filings/0001665918-26-000045.md) | [0.2](/filings/0001665918-25-000146.md) | [0.2 d](/filings/0001665918-26-000008.md) | [0.1](/filings/0001665918-26-000045.md) | [0.3](/filings/0001665918-26-000045.md) |
| Diluted EPS | $ per share | [0.38](/filings/0001665918-24-000149.md) | not reported | [0.33](/filings/0001665918-25-000085.md) | [0.80](/filings/0001665918-25-000127.md) | [0.61](/filings/0001665918-25-000146.md) | not reported | [0.49](/filings/0001665918-26-000032.md) | [0.96](/filings/0001665918-26-000045.md) | [0.67](/filings/0001665918-25-000146.md) | not reported | [0.52](/filings/0001665918-26-000032.md) | [1.24](/filings/0001665918-26-000045.md) |
| Basic EPS | $ per share | [0.38](/filings/0001665918-24-000149.md) | not reported | [0.33](/filings/0001665918-25-000085.md) | [0.81](/filings/0001665918-25-000127.md) | [0.61](/filings/0001665918-25-000146.md) | not reported | [0.50](/filings/0001665918-26-000032.md) | [0.97](/filings/0001665918-26-000045.md) | [0.68](/filings/0001665918-25-000146.md) | not reported | [0.53](/filings/0001665918-26-000032.md) | [1.26](/filings/0001665918-26-000045.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0001665918-23-000144.md) | [0.3](/filings/0001665918-26-000008.md) | [0.3](/filings/0001665918-24-000101.md) | [0.4](/filings/0001665918-24-000135.md) | [0.1](/filings/0001665918-24-000149.md) | [0.1](/filings/0001665918-26-000008.md) | [0.1](/filings/0001665918-25-000085.md) | [0.1](/filings/0001665918-25-000127.md) | [0.1](/filings/0001665918-25-000146.md) | [0.0](/filings/0001665918-26-000045.md) | [0.0](/filings/0001665918-26-000032.md) | [0.1](/filings/0001665918-26-000045.md) |
| Current assets | $bn | [4.2](/filings/0001665918-23-000144.md) | [4.0](/filings/0001665918-25-000017.md) | [4.2](/filings/0001665918-24-000101.md) | [4.3](/filings/0001665918-24-000135.md) | [4.1](/filings/0001665918-24-000149.md) | [4.0](/filings/0001665918-26-000008.md) | [4.1](/filings/0001665918-25-000085.md) | [4.2](/filings/0001665918-25-000127.md) | [4.4](/filings/0001665918-25-000146.md) | [4.2](/filings/0001665918-26-000045.md) | [4.4](/filings/0001665918-26-000032.md) | [4.4](/filings/0001665918-26-000045.md) |
| Total assets | $bn | [13.3](/filings/0001665918-23-000144.md) | [13.2](/filings/0001665918-25-000017.md) | [13.4](/filings/0001665918-24-000101.md) | [13.7](/filings/0001665918-24-000135.md) | [13.5](/filings/0001665918-24-000149.md) | [13.4](/filings/0001665918-26-000008.md) | [13.7](/filings/0001665918-25-000085.md) | [13.8](/filings/0001665918-25-000127.md) | [14.0](/filings/0001665918-25-000146.md) | [13.9](/filings/0001665918-26-000045.md) | [14.2](/filings/0001665918-26-000032.md) | [14.3](/filings/0001665918-26-000045.md) |
| Current liabilities | $bn | [3.3](/filings/0001665918-23-000144.md) | [3.1](/filings/0001665918-25-000017.md) | [3.2](/filings/0001665918-24-000101.md) | [3.4](/filings/0001665918-24-000135.md) | [3.5](/filings/0001665918-24-000149.md) | [3.3](/filings/0001665918-26-000008.md) | [3.5](/filings/0001665918-25-000085.md) | [3.6](/filings/0001665918-25-000127.md) | [3.8](/filings/0001665918-25-000146.md) | [3.6](/filings/0001665918-26-000045.md) | [3.8](/filings/0001665918-26-000032.md) | [3.9](/filings/0001665918-26-000045.md) |
| Total liabilities | $bn | [8.6](/filings/0001665918-23-000144.md) | [8.4](/filings/0001665918-25-000017.md) | [8.6](/filings/0001665918-24-000101.md) | [8.7](/filings/0001665918-24-000135.md) | [8.9](/filings/0001665918-24-000149.md) | [8.9](/filings/0001665918-26-000008.md) | [9.0](/filings/0001665918-25-000085.md) | [9.2](/filings/0001665918-25-000127.md) | [9.6](/filings/0001665918-25-000146.md) | [9.6](/filings/0001665918-26-000045.md) | [9.8](/filings/0001665918-26-000032.md) | [10.1](/filings/0001665918-26-000045.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [4.7](/filings/0001665918-24-000149.md) | [4.7](/filings/0001665918-26-000008.md) | [4.8](/filings/0001665918-25-000146.md) | [5.0](/filings/0001665918-25-000146.md) | [4.6](/filings/0001665918-25-000146.md) | [4.5](/filings/0001665918-26-000045.md) | [4.6](/filings/0001665918-26-000045.md) | [4.6](/filings/0001665918-26-000045.md) | [4.5](/filings/0001665918-25-000146.md) | [4.3](/filings/0001665918-26-000045.md) | [4.3](/filings/0001665918-26-000045.md) | [4.3](/filings/0001665918-26-000045.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [282 d](/filings/0001665918-24-000149.md) | [205 d](/filings/0001665918-26-000008.md) | [139](/filings/0001665918-25-000085.md) | [482 d](/filings/0001665918-25-000127.md) | [270 d](/filings/0001665918-25-000146.md) | [283 d](/filings/0001665918-26-000008.md) | [391](/filings/0001665918-26-000032.md) | [334 d](/filings/0001665918-26-000045.md) | [351 d](/filings/0001665918-25-000146.md) | [293 d](/filings/0001665918-26-000008.md) | [294](/filings/0001665918-26-000032.md) | [431 d](/filings/0001665918-26-000045.md) |
| Capital expenditure | $m | [59.0 d](/filings/0001665918-24-000149.md) | [142 d](/filings/0001665918-26-000008.md) | [87.0](/filings/0001665918-25-000085.md) | [69.0 d](/filings/0001665918-25-000127.md) | [80.0 d](/filings/0001665918-25-000146.md) | [105 d](/filings/0001665918-26-000008.md) | [84.0](/filings/0001665918-26-000032.md) | [77.0 d](/filings/0001665918-26-000045.md) | [115 d](/filings/0001665918-25-000146.md) | [134 d](/filings/0001665918-26-000008.md) | [98.0](/filings/0001665918-26-000032.md) | [76.0 d](/filings/0001665918-26-000045.md) |
| Share repurchases | $m | [29.0](/filings/0001665918-23-000144.md) | [65.0 d](/filings/0001665918-26-000008.md) | [13.0](/filings/0001665918-25-000085.md) | [41.0 d](/filings/0001665918-25-000127.md) | [574 d](/filings/0001665918-25-000146.md) | [320 d](/filings/0001665918-26-000008.md) | [23.0](/filings/0001665918-26-000032.md) | [247 d](/filings/0001665918-26-000045.md) | [332 d](/filings/0001665918-25-000146.md) | [324 d](/filings/0001665918-26-000008.md) | [75.0](/filings/0001665918-26-000032.md) | [370 d](/filings/0001665918-26-000045.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [251](/filings/0001665918-23-000144.md) | [252](/filings/0001665918-24-000101.md) | [251](/filings/0001665918-24-000135.md) | [249](/filings/0001665918-24-000149.md) | [248](/filings/0001665918-25-000085.md) | [248](/filings/0001665918-25-000127.md) | [244](/filings/0001665918-25-000146.md) | [234](/filings/0001665918-26-000032.md) | [233](/filings/0001665918-26-000045.md) | [228](/filings/0001665918-25-000146.md) | [223](/filings/0001665918-26-000032.md) | [221](/filings/0001665918-26-000045.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 216,330,723 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001665918-26-000045.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.